KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Guardant Health (GH) Leases (2017 - 2026)

Guardant Health's Leases history spans 9 years, with the latest figure at $158.8 million for Q4 2025.

  • On a quarterly basis, Leases rose 11.66% to $158.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $158.8 million, a 11.66% increase, with the full-year FY2025 number at $158.8 million, up 11.66% from a year prior.
  • Leases hit $158.8 million in Q4 2025 for Guardant Health, down from $163.5 million in the prior quarter.
  • Over the last five years, Leases for GH hit a ceiling of $205.7 million in Q1 2021 and a floor of $140.5 million in Q1 2025.
  • Historically, Leases has averaged $169.5 million across 5 years, with a median of $167.5 million in 2023.
  • Biggest five-year swings in Leases: skyrocketed 582.57% in 2021 and later fell 11.59% in 2024.
  • Tracing GH's Leases over 5 years: stood at $189.4 million in 2021, then fell by 8.15% to $174.0 million in 2022, then dropped by 9.42% to $157.6 million in 2023, then decreased by 9.74% to $142.3 million in 2024, then grew by 11.66% to $158.8 million in 2025.
  • Business Quant data shows Leases for GH at $158.8 million in Q4 2025, $163.5 million in Q3 2025, and $169.8 million in Q2 2025.